{"id":56240,"date":"2025-05-11T03:19:37","date_gmt":"2025-05-11T03:19:37","guid":{"rendered":"https:\/\/prosfunds.com\/?p=56240"},"modified":"2025-05-11T03:19:37","modified_gmt":"2025-05-11T03:19:37","slug":"pulse-biosciences-inc-plse-q1-2025-earnings-call-transcript","status":"publish","type":"post","link":"https:\/\/prosfunds.com\/?p=56240","title":{"rendered":"Pulse Biosciences, Inc. (PLSE) Q1 2025 Earnings Call Transcript"},"content":{"rendered":"
\n

Pulse Biosciences, Inc. (NASDAQ:PLSE<\/span>) Q1 2025 Earnings Call May 8, 2025 4:30 PM ET<\/p>\n

Company Participants<\/strong><\/p>\n

Philip Taylor – Gilmartin Group
Jon Skinner \u2013 CFO
Paul LaViolette \u2013 CEO and Co-Chairman of the Board<\/p>\n

Conference Call Participants<\/strong><\/p>\n

Operator<\/strong><\/p>\n

Good afternoon, ladies and gentlemen, and welcome to the Pulse Biosciences First Quarter 2025 Financial Results Conference Call. At this time all lines are in listen-only mode. Following the presentation we will conduct a question-and-answer session. [Operator Instructions]. This call is being recorded on Thursday, May 8, 2025. I would like to hand over the conference to the first speaker today, Trip Taylor, Investor Relations. Please go ahead.<\/p>\n

Philip Taylor<\/strong><\/p>\n

Thank you, operator. Before we begin, I would like to inform you that comments and responses to your questions during today’s call reflect management’s views as of today, May 8, 2025 only and will include forward-looking statements and opinion statements, including predictions, estimates, plans, expectations, and other similar information. Actual results may differ materially from those expressed or implied as a result of certain risks and uncertainties. These risks and uncertainties are more fully described in our press release issued earlier today and in our filings with the U.S. Securities and Exchange Commission. <\/p>\n

Our SEC filings can be found on our website or on the SEC’s website. Investors are cautioned not to place undue reliance on forward-looking statements. We disclaim any obligation to update or revise these forward-looking statements. We will also discuss certain non-GAAP financial measures. Disclosures regarding these non-GAAP financial measures, including reconciliations with the most comparable GAAP measures, can be found in the press release. Please note that this conference call will be available for audio replay on our website at pulsebiosciences.com in the News and Events section on our Investor Relations page. With that, I would now like to turn the call over to Co-Chair of the<\/p>\n<\/div>\n

Read the full article here<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Pulse Biosciences, Inc. (NASDAQ:PLSE) Q1 2025 Earnings Call May 8, 2025 4:30 PM ET Company Participants Philip Taylor – Gilmartin GroupJon Skinner \u2013 CFOPaul LaViolette \u2013 CEO and Co-Chairman of the Board Conference Call Participants Operator Good afternoon, ladies and gentlemen, and welcome to the Pulse Biosciences First Quarter 2025 Financial Results Conference Call. At […]<\/p>\n","protected":false},"author":1,"featured_media":3613,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","footnotes":""},"categories":[38],"tags":[],"class_list":{"0":"post-56240","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-news"},"yoast_head":"\nPulse Biosciences, Inc. (PLSE) Q1 2025 Earnings Call Transcript | Prosfunds<\/title>\n<meta name=\"description\" content=\"Pulse Biosciences, Inc. (NASDAQ:PLSE) Q1 2025 Earnings Call May 8, 2025 4:30 PM ET Company Participants Philip Taylor - Gilmartin GroupJon Skinner \u2013\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/prosfunds.com\/?p=56240\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pulse Biosciences, Inc. (PLSE) Q1 2025 Earnings Call Transcript | Prosfunds\" \/>\n<meta property=\"og:description\" content=\"Pulse Biosciences, Inc. (NASDAQ:PLSE) Q1 2025 Earnings Call May 8, 2025 4:30 PM ET Company Participants Philip Taylor - Gilmartin GroupJon Skinner \u2013\" \/>\n<meta property=\"og:url\" content=\"https:\/\/prosfunds.com\/?p=56240\" \/>\n<meta property=\"og:site_name\" content=\"Prosfunds\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-11T03:19:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"1200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"News Room\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"News Room\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/prosfunds.com\/?p=56240#article\",\"isPartOf\":{\"@id\":\"https:\/\/prosfunds.com\/?p=56240\"},\"author\":{\"name\":\"News Room\",\"@id\":\"https:\/\/prosfunds.com\/#\/schema\/person\/bab8f1b00ccebe43e39ff640793108e6\"},\"headline\":\"Pulse Biosciences, Inc. (PLSE) Q1 2025 Earnings Call Transcript\",\"datePublished\":\"2025-05-11T03:19:37+00:00\",\"dateModified\":\"2025-05-11T03:19:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/prosfunds.com\/?p=56240\"},\"wordCount\":315,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/prosfunds.com\/#organization\"},\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/prosfunds.com\/?p=56240#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/prosfunds.com\/?p=56240\",\"url\":\"https:\/\/prosfunds.com\/?p=56240\",\"name\":\"Pulse Biosciences, Inc. (PLSE) Q1 2025 Earnings Call Transcript | Prosfunds\",\"isPartOf\":{\"@id\":\"https:\/\/prosfunds.com\/#website\"},\"datePublished\":\"2025-05-11T03:19:37+00:00\",\"dateModified\":\"2025-05-11T03:19:37+00:00\",\"description\":\"Pulse Biosciences, Inc. (NASDAQ:PLSE) Q1 2025 Earnings Call May 8, 2025 4:30 PM ET Company Participants Philip Taylor - Gilmartin GroupJon Skinner \u2013\",\"breadcrumb\":{\"@id\":\"https:\/\/prosfunds.com\/?p=56240#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/prosfunds.com\/?p=56240\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/prosfunds.com\/?p=56240#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/prosfunds.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pulse Biosciences, Inc. (PLSE) Q1 2025 Earnings Call Transcript\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/prosfunds.com\/#website\",\"url\":\"https:\/\/prosfunds.com\/\",\"name\":\"Funding Factories\",\"description\":\"Latest Finance News and Updates\",\"publisher\":{\"@id\":\"https:\/\/prosfunds.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/prosfunds.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/prosfunds.com\/#organization\",\"name\":\"Funding Factories\",\"url\":\"https:\/\/prosfunds.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/prosfunds.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/ff-dark-logo-1.png\",\"contentUrl\":\"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/ff-dark-logo-1.png\",\"width\":780,\"height\":140,\"caption\":\"Funding Factories\"},\"image\":{\"@id\":\"https:\/\/prosfunds.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/prosfunds.com\/#\/schema\/person\/bab8f1b00ccebe43e39ff640793108e6\",\"name\":\"News Room\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/prosfunds.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/avatar_user_1_1693518183-96x96.png\",\"contentUrl\":\"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/avatar_user_1_1693518183-96x96.png\",\"caption\":\"News Room\"},\"sameAs\":[\"https:\/\/prosfunds.com\"],\"url\":\"https:\/\/prosfunds.com\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pulse Biosciences, Inc. (PLSE) Q1 2025 Earnings Call Transcript | Prosfunds","description":"Pulse Biosciences, Inc. (NASDAQ:PLSE) Q1 2025 Earnings Call May 8, 2025 4:30 PM ET Company Participants Philip Taylor - Gilmartin GroupJon Skinner \u2013","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/prosfunds.com\/?p=56240","og_locale":"en_US","og_type":"article","og_title":"Pulse Biosciences, Inc. (PLSE) Q1 2025 Earnings Call Transcript | Prosfunds","og_description":"Pulse Biosciences, Inc. (NASDAQ:PLSE) Q1 2025 Earnings Call May 8, 2025 4:30 PM ET Company Participants Philip Taylor - Gilmartin GroupJon Skinner \u2013","og_url":"https:\/\/prosfunds.com\/?p=56240","og_site_name":"Prosfunds","article_published_time":"2025-05-11T03:19:37+00:00","og_image":[{"width":1200,"height":1200,"url":"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","type":"image\/png"}],"author":"News Room","twitter_card":"summary_large_image","twitter_misc":{"Written by":"News Room","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/prosfunds.com\/?p=56240#article","isPartOf":{"@id":"https:\/\/prosfunds.com\/?p=56240"},"author":{"name":"News Room","@id":"https:\/\/prosfunds.com\/#\/schema\/person\/bab8f1b00ccebe43e39ff640793108e6"},"headline":"Pulse Biosciences, Inc. (PLSE) Q1 2025 Earnings Call Transcript","datePublished":"2025-05-11T03:19:37+00:00","dateModified":"2025-05-11T03:19:37+00:00","mainEntityOfPage":{"@id":"https:\/\/prosfunds.com\/?p=56240"},"wordCount":315,"commentCount":0,"publisher":{"@id":"https:\/\/prosfunds.com\/#organization"},"articleSection":["News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/prosfunds.com\/?p=56240#respond"]}]},{"@type":"WebPage","@id":"https:\/\/prosfunds.com\/?p=56240","url":"https:\/\/prosfunds.com\/?p=56240","name":"Pulse Biosciences, Inc. (PLSE) Q1 2025 Earnings Call Transcript | Prosfunds","isPartOf":{"@id":"https:\/\/prosfunds.com\/#website"},"datePublished":"2025-05-11T03:19:37+00:00","dateModified":"2025-05-11T03:19:37+00:00","description":"Pulse Biosciences, Inc. (NASDAQ:PLSE) Q1 2025 Earnings Call May 8, 2025 4:30 PM ET Company Participants Philip Taylor - Gilmartin GroupJon Skinner \u2013","breadcrumb":{"@id":"https:\/\/prosfunds.com\/?p=56240#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/prosfunds.com\/?p=56240"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/prosfunds.com\/?p=56240#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/prosfunds.com\/"},{"@type":"ListItem","position":2,"name":"Pulse Biosciences, Inc. (PLSE) Q1 2025 Earnings Call Transcript"}]},{"@type":"WebSite","@id":"https:\/\/prosfunds.com\/#website","url":"https:\/\/prosfunds.com\/","name":"Funding Factories","description":"Latest Finance News and Updates","publisher":{"@id":"https:\/\/prosfunds.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/prosfunds.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/prosfunds.com\/#organization","name":"Funding Factories","url":"https:\/\/prosfunds.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/prosfunds.com\/#\/schema\/logo\/image\/","url":"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/ff-dark-logo-1.png","contentUrl":"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/ff-dark-logo-1.png","width":780,"height":140,"caption":"Funding Factories"},"image":{"@id":"https:\/\/prosfunds.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/prosfunds.com\/#\/schema\/person\/bab8f1b00ccebe43e39ff640793108e6","name":"News Room","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/prosfunds.com\/#\/schema\/person\/image\/","url":"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/avatar_user_1_1693518183-96x96.png","contentUrl":"https:\/\/prosfunds.com\/wp-content\/uploads\/2023\/08\/avatar_user_1_1693518183-96x96.png","caption":"News Room"},"sameAs":["https:\/\/prosfunds.com"],"url":"https:\/\/prosfunds.com\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/prosfunds.com\/index.php?rest_route=\/wp\/v2\/posts\/56240","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/prosfunds.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/prosfunds.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/prosfunds.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/prosfunds.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=56240"}],"version-history":[{"count":1,"href":"https:\/\/prosfunds.com\/index.php?rest_route=\/wp\/v2\/posts\/56240\/revisions"}],"predecessor-version":[{"id":56241,"href":"https:\/\/prosfunds.com\/index.php?rest_route=\/wp\/v2\/posts\/56240\/revisions\/56241"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/prosfunds.com\/index.php?rest_route=\/wp\/v2\/media\/3613"}],"wp:attachment":[{"href":"https:\/\/prosfunds.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=56240"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/prosfunds.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=56240"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/prosfunds.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=56240"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}